Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements

R. Tunn; Isabelle Boutron; An‐Wen Chan; Gary S. Collins; Asbjørn Hróbjartsson; David Moher; Kenneth F. Schulz; Jennifer Anne de Beyer; Camilla Hansen Nejstgaard; Lasse Østengaard; Sally Hopewell

doi:10.1016/j.jclinepi.2024.111309

Abstract

1 min read

The forthcoming SPIRIT 2024 and CONSORT 2024 Statements will provide updated, harmonized guidance for reporting randomized controlled trial protocols and results, respectively. The simultaneous development of the SPIRIT and CONSORT checklists has been informed by current empirical evidence and extensive input from stakeholders. We hope that this report of the methods used will be helpful for developers of future reporting guidelines.

Related publications

Article2022

170 SPIRIT-outcomes and CONSORT-outcomes: enhanced trial outcome transparency, less bias, improved systematic reviews, better health

Nancy J. Butcher, Andrea Monsour, Emma J. Mew, Lisa Askie, Jeremy Grimshaw, David Moher, An‐Wen Chan, F. Gavin, Maureen A. Smith, Martin Offringa

Article2022

55 SPIRIT-outcomes and CONSORT-outcomes: enhanced trial outcome transparency, less bias, improved systematic reviews, better health

Nancy J. Butcher, Andrea Monsour, Emma J. Mew, Lisa Askie, Jeremy Grimshaw, David Moher, An‐Wen Chan, F. Gavin, Maureen A. Smith, Martin Offringa

Preprint2021

A study protocol for the development of a SPIRIT extension for trials conducted using cohorts and routinely collected data (SPIRIT-ROUTINE)

Edmund Juszczak, David Moher, Patricia M. Kearney, Megan McCarthy, Linda M. O’Keeffe, Paula Williamson, Matthew R. Sydes, Amanda Farrin, Fiona Lugg‐Widger, Gwyneth Davies, Kerry Avery, An‐Wen Chan, Linda Kwakkenbos, Brett D. Thombs, Alan Watkins, Lars G. Hemkens, Chris Gale, Merrick Zwarenstein, Sinéad Langan, Lehana Thabane

Letter2025

SPIRIT 2025 Statement

An-Wen Chan, Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F. Schulz, Gary S. Collins, R. Tunn, Rakesh Aggarwal, Michael Berkwits, Jesse A. Berlin, Nita Bhandari, Nancy J. Butcher, Marion Campbell, Runcie C.W. Chidebe, Diana Elbourne, Andrew Farmer, Dean Fergusson, Robert Golub, Steven N. Goodman, Tammy Hoffmann, John P A Ioannidis, Brennan C Kahan, Rachel L Knowles, Sarah E Lamb, Steff Lewis, Elizabeth Loder,

Article2025

Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances

Peter Gill, Lisa Campbell, Hywel C Williams, Yvette L. Kasamon, Joerg Heber, An‐Wen Chan, Nandi Siegfried, Sabine Calleja, Dawn P. Richards, Philippe Gabríel Steg, Karim Khan, Aaron Orkin, Taixiang Wu, Cindy Mulrow, Sally Hopewell, Peter Jüni, Robert Golub, Davina Ghersi, Ana Patricia Ayala, Rhoda K. Wanyenze, Kenneth F. Schulz, Isabelle Boutron, Asbjørn Hróbjartsson,